期刊文献+

痰浊为冠状动脉介入治疗后再狭窄的重要病机之一 被引量:19

Turbid-Phlegm Is An Important Pathogenesis of Restenosis after Percutaneous Transluminal Coronary Intervention
下载PDF
导出
摘要 冠状动脉介入治疗后的再狭窄发生率较高,已经证实中医药治疗有防治再狭窄作用,本文从冠脉造影结果、血脂、血黏度、纤溶系统、自由基、血浆同型半胱氨酸水平、胰岛素抵抗等多方面证据说明痰浊与冠脉介入后再狭窄有直接关系,因而指出痰浊是冠状动脉介入治疗后再狭窄的重要中医病机之一。 The occurrence rate of restenosis after percutaneous transluminal coronary intervention (PCI) was quite high, Traditional Chinese medicine (TCM) has been proved to have the effect in preventing and curing restenosis. In this article, turbid-phlegm was proved to be directly related with restenosis after PCI in aspects of coronary arteriography, blood lipid, blood viscosity, fibrolysis system, free radicals, plasma homocysteine, insulin resistance, etc. So it is one of the important pathogenetic factors of restenosis after PCI in TCM.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2005年第8期750-753,共4页 Chinese Journal of Integrated Traditional and Western Medicine
  • 相关文献

参考文献26

二级参考文献65

共引文献460

同被引文献263

引证文献19

二级引证文献121

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部